H.R. 1315 · 118th Congress · Health
PC–CARE Act
- IntroducedMar 1, 2023 Done
- CommitteeDied Jan 3, 2025 Stopped here
- House floorNot yet Not reached yet
- Senate floorNot yet Not reached yet
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
What it does
This bill establishes a committee to develop, implement, and periodically revise a plan to coordinate federal activities and programs concerning prostate cancer, including those related to research, screening, diagnosis, and treatment.
Committee members must include representatives from specified federal agencies, as well as researchers, clinicians, individuals living with prostate cancer (or their caregivers), and other stakeholders. In addition, at least half of the members must be physicians.
Congressional Research Service · summary of “Introduced in House” version · Mar 1, 2023
Who lobbies on it
No lobbying filing on file names H.R. 1315.
Organizations that named H.R. 1315 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.
Actions
3 actions · newest first- Mar 10, 2023Referred to the Subcommittee on Health.
- Mar 1, 2023Referred to the House Committee on Energy and Commerce.
- Mar 1, 2023Introduced in House